Lisa Keiser
Primary Care · Houston, TXNPI 1891468575
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 49 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 13.4% — the pattern of someone who eats at a lot of different presentations.
Across 49 payments — averaging $39.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biosense Webster, Inc.$256
- Johnson & Johnson$222
- Stryker$170
- Mimedx Group, Inc.$170
- Teva Pharmaceuticals USA, Inc.$151
- Silk Road Medical, Inc.$143
- plus $802 from 15 others
What the payments were for
- Food & beverage$1,89299%
- Entertainment$221%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biosense Webster, Inc. | 8 | $256 |
| Johnson & Johnson | 7 | $222 |
| Stryker | 6 | $170 |
| Mimedx Group, Inc. | 2 | $170 |
| Teva Pharmaceuticals USA, Inc. | 2 | $151 |
| Silk Road Medical, Inc. | 1 | $143 |
| Neurocrine Biosciences, Inc. | 1 | $129 |
| Boston Scientific | 4 | $99 |
| Corcept Therapeutics | 1 | $89 |
| Amgen | 1 | $85 |
| Biogen | 1 | $69 |
| Nevro Corp. | 1 | $50 |
| Smith+Nephew | 2 | $49 |
| Pfizer | 3 | $47 |
| Ossur Americas, Inc. | 2 | $46 |
| Integra Lifesciences Corporation | 1 | $31 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| Argentum Medical | 1 | $22 |
| Kestra Medical Technology Services, Inc. | 1 | $20 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| Cashflow Solutions, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,914 in reported general payments places this provider in the 80th percentile of 563 primary care providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 11 | $10,390 |
| Atorvastatin Calcium | 42 | $884 |
| Rosuvastatin Calcium | 15 | $695 |
| Losartan Potassium | 28 | $694 |
| Omeprazole | 13 | $420 |
| Alendronate Sodium | 12 | $300 |
| Amlodipine Besylate | 32 | $293 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 23 | $274 |
| Fluticasone Propionate | 22 | $240 |
| Metformin Hcl | 19 | $222 |
| Tizanidine Hcl | 16 | $179 |
| Gabapentin | 17 | $178 |
| Hydrochlorothiazide | 16 | $70 |
| Prednisone | 11 | $5 |
Paid to pharmacies, not to this prescriber.
Other primary care in Houston
- Mary GibbensHouston$42K
- Joanna LarsonHouston$7K
- Mei ChenHouston$4K
- Catherine PenceHouston$3K
- Phillip GulleySan Antonio$23K
- Herbert BautistaDallas$14K
- Brandi JoynerLongview$12K
- Steven ParisAustin$10K
- Hope OdomCollege Station$10K
- Arlena GraysTomball$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.